Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir MarboxilGlobeNewsWire • 10/08/24
Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro InhibitorGlobeNewsWire • 09/30/24
Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business HighlightsGlobeNewsWire • 08/15/24